Literature DB >> 20382266

Rate-dependent action potential alternans in human heart failure implicates abnormal intracellular calcium handling.

Jason D Bayer1, Sanjiv M Narayan, Gautam G Lalani, Natalia A Trayanova.   

Abstract

BACKGROUND: Alternans in action potential voltage (APV-ALT) at heart rates <110 bpm is a novel index to predict ventricular arrhythmias. However, the rate dependency of APV-ALT and its mechanisms in failing versus nonfailing human myocardium are poorly understood. It is hypothesized that APV-ALT in human heart failure (HF) reflects abnormal calcium handling.
OBJECTIVE: Using a modeling and clinical approach, our objectives were to (1) determine how APV-ALT varies with pacing rate and (2) ascertain whether abnormalities in calcium handling explain the rate dependence of APV-ALT in HF.
METHODS: APV-ALT was analyzed at several cycle lengths (CLs) using a dynamic pacing protocol applied to a human left ventricle wedge model with various alterations in calcium handling. Modeled APV-ALT was used to predict APV-ALT in left ventricle monophasic action potentials recorded from HF (n = 3) and control (n = 2) patients with the same pacing protocol.
RESULTS: Reducing the sarcoplasmic reticulum calcium uptake current < or =25%, the release current < or =11%, or the sarcolemmal L-type calcium channel current < or =43% of control predicted APV-ALT to arise at CL > or =600 ms and then increase in magnitude by >400% for CL <400 ms. In HF patients, APV-ALT arose at CL = 600 ms and then increased in magnitude by >500% at CL <350 ms. For all other model alterations and for control patients, APV-ALT occurred only at CL <500 ms.
CONCLUSIONS: APV-ALT shows differing rate dependence in HF versus control patients, arising at slower rates in HF and predicted by models with abnormal calcium handling. Future studies should investigate whether APV-ALT at slow rates identifies patients with deranged calcium handing, including HF patients before decompensation or at risk for arrhythmias. Copyright 2010 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382266      PMCID: PMC2910243          DOI: 10.1016/j.hrthm.2010.04.008

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  36 in total

Review 1.  Interpretation and classification of microvolt T wave alternans tests.

Authors:  Daniel M Bloomfield; Stefan H Hohnloser; Richard J Cohen
Journal:  J Cardiovasc Electrophysiol       Date:  2002-05

2.  Cardiac alternans induced by fibroblast-myocyte coupling: mechanistic insights from computational models.

Authors:  Yuanfang Xie; Alan Garfinkel; James N Weiss; Zhilin Qu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-29       Impact factor: 4.733

3.  Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy.

Authors:  Michael R Gold; John H Ip; Otto Costantini; Jeanne E Poole; Steven McNulty; Daniel B Mark; Kerry L Lee; Gust H Bardy
Journal:  Circulation       Date:  2008-10-27       Impact factor: 29.690

4.  High amplitude T-wave alternans precedes spontaneous ventricular tachycardia or fibrillation in ICD electrograms.

Authors:  Charles D Swerdlow; Xiaohong Zhou; Olga Voroshilovsky; Athula Abeyratne; Jeff Gillberg
Journal:  Heart Rhythm       Date:  2008-02-16       Impact factor: 6.343

5.  Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.

Authors:  Theodore Chow; Dean J Kereiakes; John Onufer; Alan Woelfel; Sinan Gursoy; Brett J Peterson; Mark L Brown; Wenji Pu; David G Benditt
Journal:  J Am Coll Cardiol       Date:  2008-11-11       Impact factor: 24.094

6.  Heart failure enhances susceptibility to arrhythmogenic cardiac alternans.

Authors:  Lance D Wilson; Darwin Jeyaraj; Xiaoping Wan; Gregory S Hoeker; Tamer H Said; Matthew Gittinger; Kenneth R Laurita; David S Rosenbaum
Journal:  Heart Rhythm       Date:  2008-11-08       Impact factor: 6.343

7.  Intracellular Ca alternans: coordinated regulation by sarcoplasmic reticulum release, uptake, and leak.

Authors:  Lai-Hua Xie; Daisuke Sato; Alan Garfinkel; Zhilin Qu; James N Weiss
Journal:  Biophys J       Date:  2008-06-06       Impact factor: 4.033

8.  Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium.

Authors:  G Hasenfuss; H Reinecke; R Studer; M Meyer; B Pieske; J Holtz; C Holubarsch; H Posival; H Just; H Drexler
Journal:  Circ Res       Date:  1994-09       Impact factor: 17.367

9.  Action potential dynamics explain arrhythmic vulnerability in human heart failure: a clinical and modeling study implicating abnormal calcium handling.

Authors:  Sanjiv M Narayan; Jason D Bayer; Gautam Lalani; Natalia A Trayanova
Journal:  J Am Coll Cardiol       Date:  2008-11-25       Impact factor: 24.094

10.  Gap junction remodelling in human heart failure is associated with increased interaction of connexin43 with ZO-1.

Authors:  Alexandra F Bruce; Stephen Rothery; Emmanuel Dupont; Nicholas J Severs
Journal:  Cardiovasc Res       Date:  2007-12-04       Impact factor: 10.787

View more
  33 in total

Review 1.  Role of substrate and triggers in the genesis of cardiac alternans, from the myocyte to the whole heart: implications for therapy.

Authors:  Faisal M Merchant; Antonis A Armoundas
Journal:  Circulation       Date:  2012-01-24       Impact factor: 29.690

2.  Frequency analysis of atrial action potential alternans: a sensitive clinical index of individual propensity to atrial fibrillation.

Authors:  Gautam G Lalani; Amir A Schricker; Paul Clopton; David E Krummen; Sanjiv M Narayan
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-08-31

3.  Mechanisms of cardiac alternans in atrial cells: intracellular Ca2⁺ disturbances lead the way.

Authors:  Héctor H Valdivia
Journal:  Circ Res       Date:  2015-02-27       Impact factor: 17.367

4.  Optical mapping of sarcoplasmic reticulum Ca2+ in the intact heart: ryanodine receptor refractoriness during alternans and fibrillation.

Authors:  Lianguo Wang; Rachel C Myles; Nicole M De Jesus; Alex K P Ohlendorf; Donald M Bers; Crystal M Ripplinger
Journal:  Circ Res       Date:  2014-02-25       Impact factor: 17.367

Review 5.  Alternans in atria: Mechanisms and clinical relevance.

Authors:  Giedrius Kanaporis; Lothar A Blatter
Journal:  Medicina (Kaunas)       Date:  2017-06-07       Impact factor: 2.430

6.  Action potential shortening rescues atrial calcium alternans.

Authors:  Giedrius Kanaporis; Zane M Kalik; Lothar A Blatter
Journal:  J Physiol       Date:  2018-12-05       Impact factor: 5.182

7.  Repolarization alternans reveals vulnerability to human atrial fibrillation.

Authors:  Sanjiv M Narayan; Michael R Franz; Paul Clopton; Etienne J Pruvot; David E Krummen
Journal:  Circulation       Date:  2011-06-06       Impact factor: 29.690

Review 8.  Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology.

Authors:  Richard L Verrier; Thomas Klingenheben; Marek Malik; Nabil El-Sherif; Derek V Exner; Stefan H Hohnloser; Takanori Ikeda; Juan Pablo Martínez; Sanjiv M Narayan; Tuomo Nieminen; David S Rosenbaum
Journal:  J Am Coll Cardiol       Date:  2011-09-20       Impact factor: 24.094

Review 9.  Computational approaches to understand cardiac electrophysiology and arrhythmias.

Authors:  Byron N Roberts; Pei-Chi Yang; Steven B Behrens; Jonathan D Moreno; Colleen E Clancy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-10       Impact factor: 4.733

10.  Prominent J-wave and T-wave alternans associated with mechanical alternans in a patient with takotsubo cardiomyopathy.

Authors:  Rintaro Hojo; Seiji Fukamizu; Takeshi Kitamura; Kota Komiyama; Yasuhiro Tanabe; Tamotsu Tejima; Mitsuhiro Nishizaki; Harumizu Sakurada; Masayasu Hiraoka
Journal:  J Arrhythm       Date:  2014-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.